HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia

Clinical trial NCT04131413 · RECRUITING

Trial details

NCT number: NCT04131413
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Human Papillomavirus Type 16 Cervical Intraepithelial Neoplasia Grade II Cervical Intraepithelial Neoplasia, Grade III

Start date: 2020-09-14
Primary completion: 2027-12-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.